NCT06222905Active, not recruiting
Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)
Analysis of Remote Monitoring / Virtual Clinic Data in Adult Patients With Cystic Fibrosis (CF)
Source: ClinicalTrials.gov · Last updated 31 May 2025
Brief summary (registry, in English)
The goal of this observational study is to learn about the impact of home monitoring in adults with cystic fibrosis. The main questions it aims to answer are: * how people with CF find using home monitoring equipment * to see if by using home monitoring data acute respiratory exacerbations (chest infections) can be detected earlier than standard care Participants will be provided with a range of home monitoring equipment - * hand held spirometer (lung function) * weighing scales * oximeter (blood oxygen levels) * activity and heart rate monitor to measure health at home several times a week. This information links to an app on a smartphone which the participant and clinicians can see.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 475 (actual)
- First submitted
- 16 Jan 2024
- Start date
- 20 Feb 2019
- Primary completion date
- 25 Jan 2024
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Diseases
- Cystic fibrosis
- NCT number
- NCT06222905
What you commit to
- Study type: Observational
- Participants enrolled: 475
- From 20 Feb 2019 to the primary completion date, 25 Jan 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Lung transplant recipients
Other
- Patients unable to provide written informed consent
- Patients unwilling to consent to their link anonymized data from home monitoring / virtual clinics being used for research
Who the study is looking for
- Diagnosis of Cystic Fibrosis based on genetic testing and/or sweat chloride levels
- Age ≥ 18 years of age
- Able to provide written informed consent
- Patients who are known to be suitable for home monitoring and able to manage the process, those currently undertaking home monitoring / virtual clinics
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Papworth Hospital NHS Foundation Trust Coordinator of this site? Confirm its status | Cambridge | United Kingdom | Unknown status |
| Royal Papworth Hospital Coordinator of this site? Confirm its status | Cambridge | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.